268 related articles for article (PubMed ID: 33977396)
1. Spontaneous intra-abdominal hemorrhage of a well-differentiated, grade 3 gastric neuroendocrine tumor during drug-based treatment.
Namikawa T; Yokota K; Yamaguchi S; Fukudome I; Munekage M; Uemura S; Maeda H; Kitagawa H; Mibu K; Kobayashi M; Hanazaki K
Clin J Gastroenterol; 2021 Aug; 14(4):1244-1249. PubMed ID: 33977396
[TBL] [Abstract][Full Text] [Related]
2. A Case of Gastric Neuroendocrine Neoplasm with Mixed Grade: a Distinct Type of "High"-grade Well-Differentiated Neuroendocrine Neoplasm.
Guadagno E; Luglio G; Iacobelli A; Borrelli G; Castaldi A; De Rosa G; Del Basso De Caro M
Endocr Pathol; 2018 Sep; 29(3):289-293. PubMed ID: 29675587
[TBL] [Abstract][Full Text] [Related]
3. The eye of the beholder: orbital metastases from midgut neuroendocrine tumors, a two institution experience.
Das S; Pineda G; Goff L; Sobel R; Berlin J; Fisher G
Cancer Imaging; 2018 Dec; 18(1):47. PubMed ID: 30522522
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine tumor G3: a pancreatic well-differentiated neuroendocrine tumor with a high proliferative rate.
Tanaka H; Matsusaki S; Baba Y; Isono Y; Kumazawa H; Sase T; Okano H; Saito T; Mukai K; Kaneko H
Clin J Gastroenterol; 2015 Dec; 8(6):414-20. PubMed ID: 26439620
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous regression of gastric gastrinoma after resection of metastases to the lesser omentum: A case report and review of literature.
Okamoto T; Yoshimoto T; Ohike N; Fujikawa A; Kanie T; Fukuda K
World J Gastroenterol; 2021 Jan; 27(1):129-142. PubMed ID: 33505155
[TBL] [Abstract][Full Text] [Related]
6. Are G3 ENETS neuroendocrine neoplasms heterogeneous?
Vélayoudom-Céphise FL; Duvillard P; Foucan L; Hadoux J; Chougnet CN; Leboulleux S; Malka D; Guigay J; Goere D; Debaere T; Caramella C; Schlumberger M; Planchard D; Elias D; Ducreux M; Scoazec JY; Baudin E
Endocr Relat Cancer; 2013 Oct; 20(5):649-57. PubMed ID: 23845449
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous hemoperitoneum as a rare presentation of gastric lesions: Two case reports.
Almeida JI; Lima C; Pinto P; Armas I; Santos T; Freitas C
Int J Surg Case Rep; 2022 Feb; 91():106769. PubMed ID: 35091354
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathologic features and prognostic analysis of 240 patients with gastric neuroendocrine neoplasms].
Liang WQ; Zhang W; Qiao S; Wang BH; Wang C; Zhuang ZW; Xi HQ; Cai AZ; Wei B; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jan; 23(1):38-43. PubMed ID: 31958929
[No Abstract] [Full Text] [Related]
9. Spontaneous rupture of a large exogastric hemangioma complicated by hemoperitoneum and sepsis.
Lin CH; Hsieh HF; Yu JC; Hsu SD; Chen CW; Liao GS; Hsieh CB
J Formos Med Assoc; 2006 Dec; 105(12):1027-30. PubMed ID: 17185247
[TBL] [Abstract][Full Text] [Related]
10. Unusual endoscopic findings of gastric neuroendocrine tumor.
Kishi K; Fujisawa A; Horikita M; Nakai Y; Ooshimo K; Kishi F; Kimura M; Lin CC; Takayama T
J Med Invest; 2015; 62(3-4):251-7. PubMed ID: 26399359
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effect of everolimus in a patient with type 3 gastric neuroendocrine tumor.
Bariani GM; Carvalheira JB; Riechelmann RP
Onkologie; 2013; 36(9):502-4. PubMed ID: 24051927
[TBL] [Abstract][Full Text] [Related]
12. Mixed adenoneuroendocrine carcinoma of the liver: A rare case report.
Yang JJ; Li ZP; Luo CL; Du Y; Lu QY; Li N; Li H; Yu TP; Huang XM
Mol Clin Oncol; 2020 Feb; 12(2):148-154. PubMed ID: 31929886
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Follow-Up of a Patient with Primary Presacral Neuroendocrine Tumor: A Case Report with Literature Review.
Kim MR; Shim HK
Am J Case Rep; 2019 Dec; 20():1969-1975. PubMed ID: 31889046
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological features and outcome of type 3 gastric neuroendocrine tumours.
Min BH; Hong M; Lee JH; Rhee PL; Sohn TS; Kim S; Kim KM; Kim JJ
Br J Surg; 2018 Oct; 105(11):1480-1486. PubMed ID: 29893418
[TBL] [Abstract][Full Text] [Related]
15. [A Case of Advanced Gastric Cancer with Liver Metastasis Treated by Curative Surgery after Chemotherapy Using S-1 plus Oxaliplatin].
Namikawa T; Kawanishi Y; Fujieda Y; Fujisawa K; Munekage E; Munekage M; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1446-1448. PubMed ID: 29394663
[TBL] [Abstract][Full Text] [Related]
16. Grade 3 well-differentiated neuroendocrine tumor of the rectum: a case report.
Ito M; Hirano Y; Isii T; Kondo H; Wang L; Asari M; Obara N; Yamaguchi S
Surg Case Rep; 2020 Jun; 6(1):130. PubMed ID: 32533349
[TBL] [Abstract][Full Text] [Related]
17. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
Tang LH; Basturk O; Sue JJ; Klimstra DS
Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
[TBL] [Abstract][Full Text] [Related]
18. Leptomeningeal metastases of a well-differentiated neuroendocrine tumour: a rare entity.
Versluis JM; Brandsma D; van den Berg JG; Tesselaar M
BMJ Case Rep; 2018 Nov; 2018():. PubMed ID: 30391925
[TBL] [Abstract][Full Text] [Related]
19. PRRT in high-grade gastroenteropancreatic neuroendocrine neoplasms (WHO G3).
Sorbye H; Kong G; Grozinsky-Glasberg S
Endocr Relat Cancer; 2020 Mar; 27(3):R67-R77. PubMed ID: 31846429
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of everolimus for the treatment of progressive gastroenteropancreatic neuroendocrine tumors: A multi-institution observational study in Taiwan.
Liu CT; Chen MH; Chen JS; Chen LT; Shan YS; Lu CH; Su YL; Ku FC; Chou WC; Chen YY
Asia Pac J Clin Oncol; 2016 Dec; 12(4):396-402. PubMed ID: 27357443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
